News

There is undoubtedly a trend of life sciences companies venturing into digital technologies, which has been steadily gaining momentum. The life sciences industry has never been an early adopter of technical novelties. However, many companies in the industry have recognized the potential benefits of digital technologies across diverse fields, including research, drug discovery, clinical trials, patient engagement, and healthcare delivery.

Janus Life Sciences acted as the official linguistic partner of the 7th All-Russian Good Manufacturing Practices (GMP) Conference, which was held in a hybrid format on September 7 and 8, 2022 at the Baikal Business Center in Irkutsk. The conference was organized by the Russian Ministry of Industry and Trade in cooperation with the Federal State Institute of Drugs and Good Practices. It brought together a wide range of pharmaceutical industry experts, representatives of government authorities, professional associations and communities, and specialists in quality control systems and GMP.